Entera Bio Ltd reports results for the quarter ended in March - Earnings Summary

Entera Bio

11/05/2023 17:19

* Entera Bio Ltd  ENTX.OQ  reported a quarterly adjusted
loss of 8
cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 12 cents per
share.
    * Reported revenue was zero​; analysts expected $100.00
thousand. 
    * Entera Bio Ltd's reported EPS for the quarter was a loss
of 8
cents​.
    * The mean earnings estimate of analysts had risen by
about 14.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Entera Bio Ltd shares had fallen by 22.5% this quarter and
gained 23.2% so far this year.
    * The company reported a quarterly loss of $2.19 million.
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 04:19 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.12          -0.08          Beat
 Dec. 31 2022      -0.11          -0.10          Beat
 Sep. 30 2022      -0.13          -0.11          Beat
 Jun. 30 2022      -0.16          -0.11          Beat